Literature DB >> 1869572

A role for ATP hydrolysis in vaccinia virus early gene transcription. Dissociation of the early transcription factor-promoter complex.

S S Broyles1.   

Abstract

Vaccinia virus RNA polymerase requires the vaccinia early transcription factor, VETF, for the in vitro initiation of transcription at early gene promoters in a reaction requiring ATP hydrolysis. VETF binds specifically to early gene promoters and has an associated DNA-dependent ATPase activity. The effect of ATP on the interaction of VETF with the promoter for the vaccinia growth factor gene promoter has been examined. ATP had no marked effect on the steady-state level of promoter binding but dramatically affected the kinetics of dissociation of VETF from the promoter. The half-life of the VETF-promoter complex was greatly reduced in the presence of ATP. The destabilization of the complex was specific for ATP and dATP, consistent with the substrate specificity of the VETF-associated ATPase. ADP or the non-hydrolyzable ATP analog adenylyl-imidodiphosphate did not destabilize the complex suggesting that ATP hydrolysis is obligatory for dissociation. These findings provide a link between the promoter binding and ATPase activities associated with VETF and suggest that the ATP-dependent dissociation of the VETF-promoter complex is an important event in the transcription of vaccinia virus early genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869572

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Ternary complex formation by vaccinia virus RNA polymerase at an early viral promoter: analysis by native gel electrophoresis.

Authors:  J Hagler; S Shuman
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  cis- and trans-acting elements involved in reactivation of vaccinia virus early transcription.

Authors:  K Masternak; R Wittek
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions.

Authors:  X Hu; L J Carroll; E J Wolffe; B Moss
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  The DNA binding domain of the vaccinia virus early transcription factor small subunit is an extended helicase-like motif.

Authors:  J Li; S S Broyles
Journal:  Nucleic Acids Res       Date:  1995-05-11       Impact factor: 16.971

5.  Temperature-sensitive mutations in the gene encoding the small subunit of the vaccinia virus early transcription factor impair promoter binding, transcription activation, and packaging of multiple virion components.

Authors:  J Li; M J Pennington; S S Broyles
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

6.  Ordered assembly of a functional preinitiation transcription complex, containing vaccinia virus early transcription factor and RNA polymerase, on an immobilized template.

Authors:  C J Baldick; M C Cassetti; N Harris; B Moss
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Cellular DNA ligase I is recruited to cytoplasmic vaccinia virus factories and masks the role of the vaccinia ligase in viral DNA replication.

Authors:  Nir Paran; Frank S De Silva; Tatiana G Senkevich; Bernard Moss
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

8.  Vaccinia virus nucleoside triphosphate phosphohydrolase I controls early and late gene expression by regulating the rate of transcription.

Authors:  M Diaz-Guerra; M Esteban
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  The small subunit of the vaccinia virus early transcription factor contacts the transcription promoter DNA.

Authors:  S S Broyles; J Li
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.

Authors:  Y Zhang; J G Keck; B Moss
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.